EE316 Cost-Effectiveness of Pretomanid-Based Regimen for Treatment of Highly Drug-Resistant Tuberculosis in a High-Income Country
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.617
https://www.valueinhealthjournal.com/article/S1098-3015(23)00717-9/fulltext
Section Title :
Section Order :
10100
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00717-9&doi=10.1016/j.jval.2023.03.617